Phase II Gleevec Idiopathic Hypereosinophilic Syndrome

This study has been withdrawn prior to enrollment.

(Withdrawn by PI due to insufficient accrual)

Sponsor:

Collaborator:

Novartis

Information provided by:

Stanford University

ClinicalTrials.gov Identifier:

NCT00230334

First received: September 28, 2005

Last updated: April 11, 2011

Last verified: April 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given